Corvus Pharmaceuticals Inc (CRVS)

NASDAQ
1.060
+0.030(+2.90%)
  • Volume:
    431,669
  • Day's Range:
    1.010 - 1.100
  • 52 wk Range:
    0.802 - 9.540

CRVS Overview

Prev. Close
1.03
Day's Range
1.01-1.1
Revenue
-
Open
1.04
52 wk Range
0.802-9.54
EPS
-0.796
Volume
431,669
Market Cap
48.88M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
295,128
P/E Ratio
-1.21
Beta
0.929
1-Year Change
-47.98%
Shares Outstanding
46,553,511
Next Earnings Date
Nov 03, 2022
What is your sentiment on Corvus Pharmaceuticals?
or
Vote to see community's results!

Corvus Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Corvus Pharmaceuticals Inc Analysis

Corvus Pharmaceuticals Inc Company Profile

Corvus Pharmaceuticals Inc Company Profile

Employees
28

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with either advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines. The company was incorporated in 2014 and is based in Burlingame, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyBuyStrong Sell
Technical IndicatorsStrong SellBuyStrong BuyStrong BuyStrong Sell
SummarySellBuyStrong BuyStrong BuyStrong Sell
  • .
    1
    • .
      0
      • .m
        0
        • .
          0
          • .
            0
            • 99% bull Monday morning
              0
              • @ do you think Tarbin will go down on Monday or more up ?
                0
            • might go down on Monday after 10-11am
              0
              • u got it.
                0
                • Let's go bro
                  0
                  • keep going down
                    0